Your browser doesn't support javascript.
loading
Antibody Isotype Switching as a Mechanism to Counter HIV Neutralization Escape.
Scheepers, Cathrine; Bekker, Valerie; Anthony, Colin; Richardson, Simone I; Oosthuysen, Brent; Moyo, Thandeka; Kgagudi, Prudence; Kitchin, Dale; Nonyane, Molati; York, Talita; Mielke, Dieter; Mabvakure, Batsirai M; Sheng, Zizhang; Lambson, Bronwen E; Ismail, Arshad; Garrett, Nigel J; Abdool Karim, Salim S; Shapiro, Lawrence; Williamson, Carolyn; Morris, Lynn; Moore, Penny L.
Afiliación
  • Scheepers C; Centre for HIV and STIs, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg 2131, South Africa; Antibody Immunity Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg 2050, South Africa.
  • Bekker V; Centre for HIV and STIs, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg 2131, South Africa.
  • Anthony C; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town 7701, South Africa.
  • Richardson SI; Centre for HIV and STIs, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg 2131, South Africa; Antibody Immunity Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg 2050, South Africa.
  • Oosthuysen B; Centre for HIV and STIs, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg 2131, South Africa.
  • Moyo T; Centre for HIV and STIs, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg 2131, South Africa; Antibody Immunity Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg 2050, South Africa.
  • Kgagudi P; Centre for HIV and STIs, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg 2131, South Africa.
  • Kitchin D; Centre for HIV and STIs, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg 2131, South Africa; Antibody Immunity Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg 2050, South Africa.
  • Nonyane M; Centre for HIV and STIs, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg 2131, South Africa.
  • York T; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town 7701, South Africa.
  • Mielke D; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town 7701, South Africa.
  • Mabvakure BM; Centre for HIV and STIs, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg 2131, South Africa; Antibody Immunity Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg 2050, South Africa.
  • Sheng Z; Department of Biochemistry and Molecular Biophysics, Columbia University, New York, NY 10032, USA; Zuckerman Brain Mind Behaviour Institute, Columbia University, New York, NY 10027, USA.
  • Lambson BE; Centre for HIV and STIs, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg 2131, South Africa; Antibody Immunity Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg 2050, South Africa.
  • Ismail A; Centre for HIV and STIs, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg 2131, South Africa.
  • Garrett NJ; Centre for the AIDS Programme of Research in South Africa (CAPRISA), KwaZulu-Natal 4013, South Africa.
  • Abdool Karim SS; Centre for the AIDS Programme of Research in South Africa (CAPRISA), KwaZulu-Natal 4013, South Africa; Department of Epidemiology, Columbia University, New York, NY 10032, USA.
  • Shapiro L; Department of Biochemistry and Molecular Biophysics, Columbia University, New York, NY 10032, USA; Zuckerman Brain Mind Behaviour Institute, Columbia University, New York, NY 10027, USA.
  • Williamson C; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town 7701, South Africa.
  • Morris L; Centre for HIV and STIs, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg 2131, South Africa; Antibody Immunity Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg 2050, South Africa; Centre for the AIDS Programme of R
  • Moore PL; Centre for HIV and STIs, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg 2131, South Africa; Antibody Immunity Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg 2050, South Africa; Institute of Infectious Disease an
Cell Rep ; 33(8): 108430, 2020 11 24.
Article en En | MEDLINE | ID: mdl-33238131
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Pruebas de Neutralización / VIH-1 / Cambio de Clase de Inmunoglobulina Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cell Rep Año: 2020 Tipo del documento: Article País de afiliación: Sudáfrica
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Pruebas de Neutralización / VIH-1 / Cambio de Clase de Inmunoglobulina Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cell Rep Año: 2020 Tipo del documento: Article País de afiliación: Sudáfrica